A multi‐hit hypothesis for an APOE4‐dependent pathophysiological state
暂无分享,去创建一个
J. Rusted | A. Penn | L. Serpell | K. Shaw | L. Minkley | O. Bonnar | Lucy J Minkley | S. King | S. Anderle | O. G. Steele | A. Stuart | C. Hall | Silvia Anderle | Oliver George Steele | Alexander Cameron Stuart | Lucy Minkley | Kira Shaw | Andrew Charles Penn | Jennifer Rusted | Louise Serpell | Catherine Hall | Sarah King | Jennifer M. Rusted
[1] Xiaochun Chen,et al. APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline , 2021, Translational Psychiatry.
[2] Rosemary J. Jackson,et al. Effect of APOE alleles on the glial transcriptome in normal aging and Alzheimer’s disease , 2021, Nature Aging.
[3] G. Gouras,et al. Astrocytic and Neuronal Apolipoprotein E Isoforms Differentially Affect Neuronal Excitability , 2021, Frontiers in Neuroscience.
[4] G. Rebeck,et al. High-fat diet increases gliosis and immediate early gene expression in APOE3 mice, but not APOE4 mice , 2021, Journal of Neuroinflammation.
[5] D. Bennett,et al. Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease , 2021, Alzheimer's research & therapy.
[6] Xiaochun Chen,et al. ApoE4 increases susceptibility to stress-induced age-dependent depression-like behavior and cognitive impairment. , 2021, Journal of psychiatric research.
[7] David A. Brafman,et al. Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids , 2021, Acta Neuropathologica.
[8] L. Tsai,et al. APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and Aβ generation , 2021, Stem cell reports.
[9] J. Tulloch,et al. Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer's disease , 2021, European journal of neurology.
[10] A. Gavin,et al. APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes , 2021, bioRxiv.
[11] R. Hammer,et al. NHE6-Depletion Corrects ApoE4-Mediated Synaptic Impairments and Reduces Amyloid Plaque Load , 2021, bioRxiv.
[12] R. Jacobs,et al. Author Correction: APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer’s mice via cyclophilin A independently of amyloid-β , 2021, Nature Aging.
[13] Pu Wang,et al. Elevating the Levels of Calcium Ions Exacerbate Alzheimer’s Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau , 2021, International journal of molecular sciences.
[14] S. King,et al. APOE4 genotype increases neuronal calcium signals and decreases pial arteriole responsivity and vasomotion in visual cortex of awake mice , 2021 .
[15] D. Bennett,et al. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer’s disease , 2021, Nature Neuroscience.
[16] Ying Han,et al. Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population , 2021, Alzheimer's research & therapy.
[17] G. Rebeck,et al. Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation , 2021, Glia.
[18] Keqiang He,et al. Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory , 2021, Neuron.
[19] G. Gouras,et al. APOE4 Affects Basal and NMDAR-Mediated Protein Synthesis in Neurons by Perturbing Calcium Homeostasis , 2020, The Journal of Neuroscience.
[20] David A. Brafman,et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids , 2020, Nature Communications.
[21] L. Tsai,et al. PICALM Rescues Endocytic Defects Caused by the Alzheimer's Disease Risk Factor APOE4. , 2020, Cell reports.
[22] C. Howarth,et al. More than just summed neuronal activity: how multiple cell types shape the BOLD response , 2020, Philosophical Transactions of the Royal Society B.
[23] G. Rebeck,et al. ApoE Lipidation as a Therapeutic Target in Alzheimer’s Disease , 2020, International journal of molecular sciences.
[24] Ching-On Wong. Endosomal-Lysosomal Processing of Neurodegeneration-Associated Proteins in Astrocytes , 2020, International journal of molecular sciences.
[25] Melanie A. Huntley,et al. Alzheimer’s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation , 2020, Cell reports.
[26] C. Finch,et al. APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease , 2020, Frontiers in Aging Neuroscience.
[27] G. Perea,et al. Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice , 2020, Molecular Neurodegeneration.
[28] Matheus B. Victor,et al. Reconstruction of the human blood–brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes , 2020, Nature Medicine.
[29] M. Sabbagh,et al. Effect of ApoE isoforms on mitochondria in Alzheimer disease , 2020, Neurology.
[30] R. Lipton,et al. APOE ε4 and the influence of sex, age, vascular risk factors, and ethnicity on cognitive decline. , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.
[31] D. Wilcock,et al. The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer’s Disease , 2020, Frontiers in Immunology.
[32] A. Fagan,et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline , 2020, Nature.
[33] Y. Asmann,et al. Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways , 2020, Neuron.
[34] J. Grutzendler,et al. TREM2: Modulator of Lipid Metabolism in Microglia , 2020, Neuron.
[35] Tzong-Shiue Yu,et al. Apolipoprotein E regulates the maturation of injury-induced adult-born hippocampal neurons following traumatic brain injury , 2020, PloS one.
[36] Xianlin Han,et al. Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome , 2020, Nature Communications.
[37] J. Rusted,et al. Mid age APOE ε4 carriers show memory-related functional differences and disrupted structure-function relationships in hippocampal regions , 2020, Scientific Reports.
[38] Juan Maldonado Weng,et al. Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How , 2020, Neurobiology of Disease.
[39] J. Arbonés-Mainar,et al. Beyond the CNS: The many peripheral roles of APOE , 2020, Neurobiology of Disease.
[40] W. Banks,et al. ApoE and cerebral insulin: Trafficking, receptors, and resistance , 2020, Neurobiology of Disease.
[41] Matthew S. Gentry,et al. APOE alters glucose flux through central carbon pathways in astrocytes , 2020, Neurobiology of Disease.
[42] G. Rebeck,et al. APOE in the normal brain , 2020, Neurobiology of Disease.
[43] N. Chandel,et al. Mitochondrial TCA cycle metabolites control physiology and disease , 2020, Nature Communications.
[44] Steve Lianoglou,et al. TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge , 2019, Neuron.
[45] H. Chui,et al. ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes , 2019, The Journal of Neuroscience.
[46] H. Bian,et al. Carnosic Acid Reverses the Inhibition of ApoE4 on Cell Surface Level of ApoER2 and Reelin Signaling Pathway. , 2019, Journal of Alzheimer's disease : JAD.
[47] C. Finch,et al. The Exposome in Human Evolution: From Dust to Diesel , 2019, The Quarterly Review of Biology.
[48] Franz Resch,et al. [Early Life Stress]. , 2019, Praxis der Kinderpsychologie und Kinderpsychiatrie.
[49] Hailan Yao,et al. Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities , 2019, Front. Cell. Neurosci..
[50] Dean P. Jones,et al. Cyclic O3 exposure synergizes with aging leading to memory impairment in male APOE ε3, but not APOE ε4, targeted replacement mice , 2019, Neurobiology of Aging.
[51] G. Cenini,et al. Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update , 2019, Front. Pharmacol..
[52] G. Petsko,et al. ENDOSOMAL TRAFFIC JAMS REPRESENT A PATHOGENIC HUB AND THERAPEUTIC TARGET IN ALZHEIMER’S DISEASE , 2019, Alzheimer's & Dementia.
[53] Yadong Huang,et al. Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease , 2019, Molecular Neurodegeneration.
[54] Youssra K Al-Hilaly,et al. The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease , 2019, Journal of molecular biology.
[55] N. V. van Nuland,et al. Apolipoprotein E associated with reconstituted high‐density lipoprotein‐like particles is protected from aggregation , 2019, FEBS letters.
[56] Rosemary J. Jackson,et al. Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype , 2019, Acta Neuropathologica Communications.
[57] M. Glatzel,et al. Phagocytosis of Apoptotic Cells Is Specifically Upregulated in ApoE4 Expressing Microglia in vitro , 2019, Front. Cell. Neurosci..
[58] L. Frank,et al. Early Hippocampal Sharp-Wave Ripple Deficits Predict Later Learning and Memory Impairments in an Alzheimer’s Disease Mouse Model , 2019, bioRxiv.
[59] R. Kukreti,et al. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases , 2019, Molecules.
[60] K. Gibas,et al. APOE ε4, the door to insulin-resistant dyslipidemia and brain fog? A case study , 2019, Alzheimer's & dementia.
[61] A. Fagan,et al. Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network , 2019, Neurobiology of Aging.
[62] Brandon C Farmer,et al. Apolipoprotein E4 Alters Astrocyte Fatty Acid Metabolism and Lipid Droplet Formation , 2019, Cells.
[63] C. Weber,et al. ApoE attenuates unresolvable inflammation by complex formation with activated C1q , 2019, Nature Medicine.
[64] N. Fitz,et al. The Role of APOE and TREM2 in Alzheimer′s Disease—Current Understanding and Perspectives , 2018, International journal of molecular sciences.
[65] A. Fagan,et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction , 2018, Nature Medicine.
[66] E. Fraenkel,et al. APOE4 is Associated with Differential Regional Vulnerability to Bioenergetic Deficits in Aged APOE Mice , 2018, Scientific Reports.
[67] Rosemary J. Jackson,et al. Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease , 2018, Neuropathology and applied neurobiology.
[68] P. Mathews,et al. Apolipoprotein E4 genotype compromises brain exosome production , 2018, Brain : a journal of neurology.
[69] T. Südhof,et al. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer’s Disease Risk , 2018, bioRxiv.
[70] J. Mandelblatt,et al. Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy , 2018, Neurotoxicity Research.
[71] G. Shulman,et al. Mechanisms of Insulin Action and Insulin Resistance. , 2018, Physiological reviews.
[72] Henning U Voss,et al. Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function , 2018, Nature Communications.
[73] Tuan Leng Tay,et al. Unique microglia recovery population revealed by single-cell RNAseq following neurodegeneration , 2018, Acta neuropathologica communications.
[74] D. Holtzman,et al. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight , 2018, Nature Reviews Immunology.
[75] Tzong-Shiue Yu,et al. ApoE Regulates the Development of Adult Newborn Hippocampal Neurons , 2018, eNeuro.
[76] R. Rao,et al. Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH , 2018, Proceedings of the National Academy of Sciences.
[77] Elizabeta Gjoneska,et al. APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types , 2018, Neuron.
[78] S. Villapol,et al. Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury , 2018, Molecular Neurodegeneration.
[79] Daniel R. Dries,et al. APOE gene and neuropsychiatric disorders and endophenotypes: A comprehensive review , 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[80] G. Bu,et al. Apolipoprotein E, Receptors, and Modulation of Alzheimer’s Disease , 2018, Biological Psychiatry.
[81] A. Saghatelian,et al. The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis , 2018, The Journal of Biological Chemistry.
[82] Yadong Huang,et al. Gain of toxic Apolipoprotein E4 effects in Human iPSC-Derived Neurons Is Ameliorated by a Small-Molecule Structure Corrector , 2018, Nature Medicine.
[83] Berislav V. Zlokovic,et al. Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders , 2018, Nature Reviews Neurology.
[84] M. Cookson,et al. The Endosomal–Lysosomal Pathway Is Dysregulated by APOE4 Expression in Vivo , 2017, Front. Neurosci..
[85] J. Raber,et al. Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[86] Geoffrey M. Barrett,et al. Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer’s disease-like pathology , 2017, Nature Communications.
[87] M. Welte,et al. Lipid droplet functions beyond energy storage. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[88] C. Iadecola. The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease , 2017, Neuron.
[89] G. Bu,et al. Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes , 2017, Neuron.
[90] Markus Glatzel,et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. , 2017, Immunity.
[91] Nick C Fox,et al. ApoE influences regional white-matter axonal density loss in Alzheimer's disease , 2017, Neurobiology of Aging.
[92] F. Calon,et al. Docosahexaenoic acid prevents cognitive deficits in human apolipoprotein E epsilon 4-targeted replacement mice , 2017, Neurobiology of Aging.
[93] J. Schug,et al. Gene co-expression networks identify Trem2 and Tyrobp as major hubs in human APOE expressing mice following traumatic brain injury , 2017, Neurobiology of Disease.
[94] L. Farde,et al. Differential Effect of APOE Alleles on Brain Glucose Metabolism in Targeted Replacement Mice: An [18F]FDG-μPET Study , 2017, Journal of Alzheimer's disease reports.
[95] Jiong Shi,et al. Hippocampal synaptic and neural network deficits in young mice carrying the human APOE4 gene , 2017, CNS neuroscience & therapeutics.
[96] S. Villapol,et al. Reduced cortical excitatory synapse number in APOE4 mice is associated with increased calcineurin activity , 2017, Neuroreport.
[97] Gokula Mohan,et al. Neuroinflammation pathways: a general review , 2017, The International journal of neuroscience.
[98] I. Amit,et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease , 2017, Cell.
[99] Carl Frieden,et al. A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain–domain interactions , 2017, Proceedings of the National Academy of Sciences.
[100] J. Herz,et al. ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease , 2017, Trends in Endocrinology & Metabolism.
[101] P. Ladd,et al. Faculty Opinions recommendation of Apoe2, apoe3, and apoe4 differentially stimulate APP transcription and aβ secretion. , 2017 .
[102] William Charles Kreisl,et al. Neuroinflammation in Neurodegenerative Disorders—a Review , 2017, Current Neurology and Neuroscience Reports.
[103] G. Rebeck,et al. The role of APOE on lipid homeostasis and inflammation in normal brains , 2017, Journal of Lipid Research.
[104] N. Maeda,et al. Gene-environment interaction between lead and Apolipoprotein E4 causes cognitive behavior deficits in mice , 2017, Molecular Neurodegeneration.
[105] S. Salim,et al. Oxidative Stress and the Central Nervous System , 2017, The Journal of Pharmacology and Experimental Therapeutics.
[106] R. Rimondini,et al. Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis , 2016, Journal of Alzheimer's disease : JAD.
[107] G. Sobue,et al. Exosome secretion is a key pathway for clearance of pathological TDP-43. , 2016, Brain : a journal of neurology.
[108] P. Calder. Docosahexaenoic Acid , 2016, Annals of Nutrition and Metabolism.
[109] B. Cosquer,et al. APOE-Sensitive Cholinergic Sprouting Compensates for Hippocampal Dysfunctions Due to Reduced Entorhinal Input , 2016, The Journal of Neuroscience.
[110] G. Rebeck,et al. Apolipoprotein E Genotype Affects Size of ApoE Complexes in Cerebrospinal Fluid , 2016, Journal of Neuropathology and Experimental Neurology.
[111] Luca Marchetti,et al. Integration of transcriptomic and genomic data suggests candidate mechanisms for APOE4-mediated pathogenic action in Alzheimer’s disease , 2016, Scientific Reports.
[112] J. Raber,et al. Genotype differences in anxiety and fear learning and memory of WT and ApoE4 mice associated with enhanced generation of hippocampal reactive oxygen species , 2016, Journal of neurochemistry.
[113] G. Rimbach,et al. APOE genotype and stress response - a mini review , 2016, Lipids in Health and Disease.
[114] J. Diedrich,et al. HtrA1 Proteolysis of ApoE In Vitro Is Allele Selective. , 2016, Journal of the American Chemical Society.
[115] Jing Zhang,et al. Early-life stress leads to impaired spatial learning and memory in middle-aged ApoE4-TR mice , 2016, Molecular Neurodegeneration.
[116] Norbert Schuff,et al. Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis , 2016, Nature Communications.
[117] S. Gratteri,et al. Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease , 2016, BioMed research international.
[118] C. Brayne,et al. Microglial immunophenotype in dementia with Alzheimer’s pathology , 2016, Journal of Neuroinflammation.
[119] S. Dumanis,et al. Identification and modification of amyloid-independent phenotypes of APOE4 mice , 2016, Experimental Neurology.
[120] R. Mahley. Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism. , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[121] Valerio Zerbi,et al. A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 Mice , 2016, Neural plasticity.
[122] Yadong Huang,et al. Enhancing GABA Signaling during Middle Adulthood Prevents Age-Dependent GABAergic Interneuron Decline and Learning and Memory Deficits in ApoE4 Mice , 2016, The Journal of Neuroscience.
[123] Guojun Bu,et al. The role of APOE in cerebrovascular dysfunction , 2016, Acta Neuropathologica.
[124] S. Schmid,et al. Endocytic pathways and endosomal trafficking: a primer , 2016, Wiener Medizinische Wochenschrift.
[125] D. Bredesen,et al. Direct Transcriptional Effects of Apolipoprotein E , 2016, The Journal of Neuroscience.
[126] Wei Zhang,et al. Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[127] W. Funkhouser,et al. APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction , 2015, PLoS biology.
[128] Matthew C Kiernan,et al. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes. , 2015, Brain : a journal of neurology.
[129] S. Younkin,et al. Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)* , 2015, The Journal of Biological Chemistry.
[130] M. Farzan,et al. The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E* , 2015, The Journal of Biological Chemistry.
[131] J. Zhong,et al. Effects of ApoE on intracellular calcium levels and apoptosis of neurons after mechanical injury , 2015, Neuroscience.
[132] M. Hutchison,et al. The role of apolipoprotein E episilon (ɛ)-4 allele on outcome following traumatic brain injury: A systematic review , 2015, Brain injury.
[133] E. Gratton,et al. LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling , 2015, eLife.
[134] J. Domingo,et al. Chronic exposure to chlorpyrifos triggered body weight increase and memory impairment depending on human apoE polymorphisms in a targeted replacement mouse model , 2015, Physiology & Behavior.
[135] M. Cusimano,et al. Association of the APOE-ε4 allele with outcome of traumatic brain injury in children and youth: a meta-analysis and meta-regression , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[136] Pinal N. Kanabar,et al. APOE‐modulated Aβ‐induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective , 2015, Journal of neurochemistry.
[137] M. LaDu,et al. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice , 2015, Molecular Neurodegeneration.
[138] Huaxi Xu,et al. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice , 2015, Molecular Neurodegeneration.
[139] K. Katayama,et al. Reelin receptors ApoER2 and VLDLR are expressed in distinct spatiotemporal patterns in developing mouse cerebral cortex , 2015, The Journal of comparative neurology.
[140] T. Montine,et al. APOE genotype‐dependent modulation of astrocyte chemokine CCL3 production , 2015, Glia.
[141] F. Calon,et al. Human Apolipoprotein E ε4 Expression Impairs Cerebral Vascularization and Blood—Brain Barrier Function in Mice , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[142] R. Mahley,et al. Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases , 2014, Neurobiology of Disease.
[143] Guoqiang Bi,et al. Cumulative effects of the ApoE genotype and gender on the synaptic proteome and oxidative stress in the mouse brain. , 2014, International Journal of Neuropsychopharmacology.
[144] Valerio Zerbi,et al. Resting-State Functional Connectivity Changes in Aging apoE4 and apoE-KO Mice , 2014, The Journal of Neuroscience.
[145] A. Gillespie,et al. Apolipoprotein E4 Produced in GABAergic Interneurons Causes Learning and Memory Deficits in Mice , 2014, Journal of Neuroscience.
[146] C. Low,et al. Reduced neuronal signaling in the ageing apolipoprotein-E4 targeted replacement female mice , 2014, Scientific Reports.
[147] S. D. Moore,et al. Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice , 2014, Neurobiology of Aging.
[148] J. Herz,et al. More than Cholesterol Transporters: Lipoprotein Receptors in CNS Function and Neurodegeneration , 2014, Neuron.
[149] P. Blackshear,et al. APOε4 is associated with enhanced in vivo innate immune responses in human subjects. , 2014, The Journal of allergy and clinical immunology.
[150] G. Rebeck,et al. Extracellular Proteolysis of Apolipoprotein E (apoE) by Secreted Serine Neuronal Protease , 2014, PloS one.
[151] D. Attwell,et al. Capillary pericytes regulate cerebral blood flow in health and disease , 2014, Nature.
[152] S. Coons,et al. Association of amyloid burden, brain atrophy and memory deficits in aged apolipoprotein ε4 mice. , 2014, Current Alzheimer research.
[153] Guojun Bu,et al. ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners? , 2014, Neuron.
[154] H. Meziane,et al. Impact of the apolipoprotein E polymorphism, age and sex on neurogenesis in mice: Pathophysiological relevance for Alzheimer's disease? , 2014, Brain Research.
[155] Chunjiang Yu,et al. ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro , 2013, ASN neuro.
[156] D. Bredesen,et al. Neuroprotective Sirtuin ratio reversed by ApoE4 , 2013, Proceedings of the National Academy of Sciences.
[157] T. Montine,et al. Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial. , 2013, JAMA neurology.
[158] D. Holtzman,et al. In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis , 2013, Molecular Neurodegeneration.
[159] Yadong Huang,et al. Cellular Source-Specific Effects of Apolipoprotein (Apo) E4 on Dendrite Arborization and Dendritic Spine Development , 2013, PloS one.
[160] K. Rosenblum,et al. ApoE ε4 is associated with eIF2α phosphorylation and impaired learning in young mice , 2013, Neurobiology of Aging.
[161] Huaxi Xu,et al. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.
[162] J. Raber,et al. ApoE isoform modulates effects of cranial 56Fe irradiation on spatial learning and memory in the water maze , 2013, Behavioural Brain Research.
[163] Yadong Huang,et al. Apolipoprotein E4 Causes Age- and Sex-Dependent Impairments of Hilar GABAergic Interneurons and Learning and Memory Deficits in Mice , 2012, PloS one.
[164] W. Jagust,et al. Apolipoprotein E, Not Fibrillar β-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging , 2012, The Journal of Neuroscience.
[165] R. Mahley,et al. Apolipoprotein E Sets the Stage: Response to Injury Triggers Neuropathology , 2012, Neuron.
[166] L. Westlye,et al. Effects of APOE on brain white matter microstructure in healthy adults , 2012, Neurology.
[167] Hong Yang,et al. Apolipoprotein E4 Is Deficient in Inducing Macrophage ABCA1 Expression and Stimulating the Sp1 Signaling Pathway , 2012, PloS one.
[168] R. Carare,et al. Disruption of Arterial Perivascular Drainage of Amyloid-β from the Brains of Mice Expressing the Human APOE ε4 Allele , 2012, PloS one.
[169] Steven Hou,et al. Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β. , 2012, Brain : a journal of neurology.
[170] A. Jaeschke,et al. Apolipoprotein E4 Impairs Macrophage Efferocytosis and Potentiates Apoptosis by Accelerating Endoplasmic Reticulum Stress* , 2012, The Journal of Biological Chemistry.
[171] Robert V Farese,et al. Lipid droplets and cellular lipid metabolism. , 2012, Annual review of biochemistry.
[172] S. Dumanis,et al. APOE genotype alters glial activation and loss of synaptic markers in mice , 2012, Glia.
[173] Clare E. Mackay,et al. The effects of APOE-ε4 on the BOLD response , 2012, Neurobiology of Aging.
[174] Gui-rong Zhang,et al. Development and Stem Cells Research Article , 2022 .
[175] C. Brayne,et al. Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer's pathology and APOE genotype , 2011, Neurobiology of Aging.
[176] Klaus P. Ebmeier,et al. The APOE ɛ4 allele modulates brain white matter integrity in healthy adults , 2011, Molecular Psychiatry.
[177] M. Fessler,et al. Intracellular Lipid Flux and Membrane Microdomains as Organizing Principles in Inflammatory Cell Signaling , 2011, The Journal of Immunology.
[178] Ralph A. Nixon,et al. Autophagy failure in Alzheimer's disease—locating the primary defect , 2011, Neurobiology of Disease.
[179] A. von Eckardstein,et al. Apolipoprotein E Induces Antiinflammatory Phenotype in Macrophages , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[180] P. Grammas,et al. Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease , 2011, Journal of Neuroinflammation.
[181] Scott A. Peterson,et al. Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors* , 2011, The Journal of Biological Chemistry.
[182] S. D. Han,et al. The Apolipoprotein E Antagonistic Pleiotropy Hypothesis: Review and Recommendations , 2011, International journal of Alzheimer's disease.
[183] Paul M. Matthews,et al. Differential effects of the APOE genotype on brain function across the lifespan , 2011, NeuroImage.
[184] M. Mattson,et al. Selective Vulnerability of Neurons in Layer II of the Entorhinal Cortex during Aging and Alzheimer's Disease , 2010, Neural plasticity.
[185] R. Mahley,et al. Apolipoprotein E4 Domain Interaction Mediates Detrimental Effects on Mitochondria and Is a Potential Therapeutic Target for Alzheimer Disease* , 2010, The Journal of Biological Chemistry.
[186] Yadong Huang,et al. Apolipoprotein E4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice , 2010, The Journal of Neuroscience.
[187] L. Mucke,et al. Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice. , 2010, The American journal of pathology.
[188] H. Vinters,et al. Synapse loss in dementias , 2010, Journal of neuroscience research.
[189] V. Mathura,et al. Apolipoprotein E genotype and oxidative stress response to traumatic brain injury , 2010, Neuroscience.
[190] J. Herz,et al. ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling , 2010, Proceedings of the National Academy of Sciences.
[191] D. Hui,et al. Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms. , 2010, The Biochemical journal.
[192] R. Mahley,et al. GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. , 2009, Cell stem cell.
[193] E. Weeber,et al. ApoE4 Decreases Spine Density and Dendritic Complexity in Cortical Neurons In Vivo , 2009, The Journal of Neuroscience.
[194] Zhao Wang,et al. ApoE 4 reduces the expression of Aβ degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons , 2009, Neuroscience Letters.
[195] I. Mikhailenko,et al. Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation , 2009, Journal of Neuroimmunology.
[196] Carol A. Colton,et al. APOE genotype-specific differences in the innate immune response , 2009, Neurobiology of Aging.
[197] M. Michikawa,et al. Apolipoprotein E4 (1–272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells , 2009, Molecular Neurodegeneration.
[198] M. Michikawa,et al. Mechanism underlying apolipoprotein E (ApoE) isoform‐dependent lipid efflux from neural cells in culture , 2009, Journal of neuroscience research.
[199] K. Weisgraber,et al. Apolipoprotein E4 Domain Interaction Induces Endoplasmic Reticulum Stress and Impairs Astrocyte Function* , 2009, The Journal of Biological Chemistry.
[200] R. Ph. Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's disease. , 2009 .
[201] M. Puzianowska-Kuźnicka,et al. The ER and ageing II: Calcium homeostasis , 2009, Ageing Research Reviews.
[202] Carl W. Cotman,et al. Exercise improves cognition and hippocampal plasticity in APOE ε4 mice , 2009, Alzheimer's & Dementia.
[203] E. Weeber,et al. ApoE isoform-dependent changes in hippocampal synaptic function , 2009, Molecular Neurodegeneration.
[204] A. D. de Craen,et al. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age , 2009, Neurology.
[205] M. Burns,et al. Low‐density lipoprotein receptors regulate microglial inflammation through c‐Jun N‐terminal kinase , 2009, Glia.
[206] M. Pangalos,et al. Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels , 2008, The Journal of Neuroscience.
[207] Z. Rahimi,et al. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease. , 2008, Clinical biochemistry.
[208] Mark W. Bondi,et al. Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis , 2008, Alzheimer's & Dementia.
[209] A. Roses,et al. Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons , 2008, Proceedings of the National Academy of Sciences.
[210] B. Zlokovic. The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.
[211] Nicolas Cherbuin,et al. Neuroimaging and APOE Genotype: A Systematic Qualitative Review , 2007, Dementia and Geriatric Cognitive Disorders.
[212] T. Foster,et al. Calcium homeostasis and modulation of synaptic plasticity in the aged brain , 2007, Aging cell.
[213] S. Fujita,et al. Novel action of apolipoprotein E (ApoE): ApoE isoform specifically inhibits lipid-particle-mediated cholesterol release from neurons , 2007, Molecular Neurodegeneration.
[214] A. Minihane,et al. Differential effects of apolipoprotein E3 and E4 on markers of oxidative status in macrophages. , 2007, The British journal of nutrition.
[215] T. Montine,et al. Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity , 2006, Journal of Neuroinflammation.
[216] K. Weisgraber,et al. Apolipoprotein E structure: insights into function. , 2006, Trends in biochemical sciences.
[217] David Walker,et al. Profile and Regulation of Apolipoprotein E (ApoE) Expression in the CNS in Mice with Targeting of Green Fluorescent Protein Gene to the ApoE Locus , 2006, The Journal of Neuroscience.
[218] T. Montine,et al. Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice , 2006 .
[219] T. Montine,et al. Neurotoxicity from innate immune response is greatest with targeted replacement of ε4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[220] G. Schellenberg,et al. Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype , 2006, Neurobiology of Aging.
[221] O. Gureje,et al. APOE ε4 is not associated with Alzheimer's disease in elderly Nigerians , 2006 .
[222] R. Elkon,et al. Apolipoprotein E4 enhances brain inflammation by modulation of the NF-κB signaling cascade , 2005, Neurobiology of Disease.
[223] A. LeBlanc,et al. The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death. , 2005, Current Alzheimer research.
[224] John W. Ferkany,et al. Receptor Binding , 2005 .
[225] D. Hui,et al. The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity. , 2005, Biochemistry.
[226] D. C. Harris,et al. Multiple pathways of apolipoprotein E signaling in primary neurons , 2005, Journal of neurochemistry.
[227] M. Vitek,et al. A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury , 2005, Experimental Neurology.
[228] S. D. Moore,et al. Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology , 2005, Neurobiology of Disease.
[229] D. Schmechel,et al. Marked regional differences of brain human apolipoprotein e expression in targeted replacement mice , 2004, Neuroscience.
[230] D. Grainger,et al. Apolipoprotein E Modulates Clearance of Apoptotic Bodies In Vitro and In Vivo, Resulting in a Systemic Proinflammatory State in Apolipoprotein E-Deficient Mice1 , 2004, The Journal of Immunology.
[231] R. Mahley,et al. Increased tau Phosphorylation in Apolipoprotein E4 Transgenic Mice Is Associated with Activation of Extracellular Signal-regulated Kinase , 2004, Journal of Biological Chemistry.
[232] D. Butterfield,et al. Effects of apolipoprotein E on the human immunodeficiency virus protein tat in neuronal cultures and synaptosomes , 2004, Journal of neuroscience research.
[233] B. Hyman,et al. Apolipoprotein E Receptors Mediate Neurite Outgrowth through Activation of p44/42 Mitogen-activated Protein Kinase in Primary Neurons* , 2004, Journal of Biological Chemistry.
[234] J. Wesson Ashford,et al. ApoE genotype accounts for the vast majority of AD risk and AD pathology , 2004, Neurobiology of Aging.
[235] Tony Wyss-Coray,et al. Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice , 2004, The Journal of Neuroscience.
[236] W. Strittmatter,et al. APOE genotype-specific differences in human and mouse macrophage nitric oxide production , 2004, Journal of Neuroimmunology.
[237] S. Paul,et al. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes , 2004, Journal of neurochemistry.
[238] J. Sweatt,et al. Receptor Clustering Is Involved in Reelin Signaling , 2004, Molecular and Cellular Biology.
[239] R. Mahley,et al. Astroglial Regulation of Apolipoprotein E Expression in Neuronal Cells , 2004, Journal of Biological Chemistry.
[240] B. Hyman,et al. ApoE isoforms affect neuronal N-methyl-d-aspartate calcium responses and toxicity via receptor-mediated processes , 2003, Neuroscience.
[241] D. Holtzman,et al. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients , 2003, Neuroscience.
[242] G. Alexander,et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[243] M. Vitek,et al. APOE Genotype and an ApoE-mimetic Peptide Modify the Systemic and Central Nervous System Inflammatory Response* , 2003, Journal of Biological Chemistry.
[244] L. Mucke,et al. Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[245] D. Ashline,et al. Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue. , 2002, Free radical biology & medicine.
[246] C. Colton,et al. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress , 2002, Neurobiology of Aging.
[247] W. Schneider,et al. The PX‐domain protein SNX17 interacts with members of the LDL receptor family and modulates endocytosis of the LDL receptor , 2002, The EMBO journal.
[248] C. Colton,et al. Apolipoprotein E isoform mediated regulation of nitric oxide release. , 2002, Free radical biology & medicine.
[249] M. Donowitz,et al. Human Na(+)/H(+) exchanger isoform 6 is found in recycling endosomes of cells, not in mitochondria. , 2002, American journal of physiology. Cell physiology.
[250] J. Gilbert,et al. Defective neuronal sprouting by human apolipoprotein E4 is a gain‐of‐negative function , 2002, Journal of neuroscience research.
[251] D. Lala. Liver X Receptors , 2002 .
[252] E. Masliah,et al. Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis , 2002, Journal of neuroscience research.
[253] Xianlin Han,et al. Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice , 2001, Neurochemistry International.
[254] Robert V Farese,et al. Introduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[255] R. Mahley,et al. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[256] K. Horsburgh,et al. Alterations in ApoE and ApoJ in Relation to Degeneration and Regeneration in a Mouse Model of Entorhinal Cortex Lesion , 2001, Experimental Neurology.
[257] O Almkvist,et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment , 2001, Neuroreport.
[258] D. Levy,et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. , 2001, Atherosclerosis.
[259] T. Ogihara,et al. Apolipoprotein E4 Stimulates cAMP Response Element-binding Protein Transcriptional Activity through the Extracellular Signal-regulated Kinase Pathway* , 2001, The Journal of Biological Chemistry.
[260] Johnm . Taylor,et al. Two Distal Downstream Enhancers Direct Expression of the Human Apolipoprotein E Gene to Astrocytes in the Brain , 2001, The Journal of Neuroscience.
[261] S. Pizzo,et al. Downregulation of Microglial Activation by Apolipoprotein E and ApoE-Mimetic Peptides , 2001, Experimental Neurology.
[262] E. Boerwinkle,et al. Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. , 2000, Genome research.
[263] J. Vaupel,et al. Estimation of apolipoprotein E genotype‐specific relative mortality risks from the distribution of genotypes in centenarians and middle‐aged men: Apolipoprotein E gene is a “frailty gene,” not a “longevity gene” , 2000, Genetic epidemiology.
[264] D. Breuillé,et al. High-fat diet. , 2000 .
[265] B T Hyman,et al. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. , 2000, The American journal of pathology.
[266] M. Stewart,et al. Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human Apolipoprotein E4 transgenic mice , 2000, Neuroscience.
[267] M. Mattson,et al. A Mechanism for the Neuroprotective Effect of Apolipoprotein E , 2000, Journal of neurochemistry.
[268] L. Mucke,et al. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease , 2000, Neuroscience.
[269] Q. Fan,et al. Apolipoprotein E Exhibits Isoform‐Specific Promotion of Lipid Efflux from Astrocytes and Neurons in Culture , 2000, Journal of neurochemistry.
[270] Y. Christen,et al. Oxidative Insults Are Associated with Apolipoprotein E Genotype in Alzheimer's Disease Brain , 2000, Neurobiology of Disease.
[271] M. Mattson,et al. Truncated Apolipoprotein E (ApoE) Causes Increased Intracellular Calcium and May Mediate ApoE Neurotoxicity , 1999, The Journal of Neuroscience.
[272] Matthias Orth,et al. Expression of Human Apolipoprotein E3 or E4 in the Brains ofApoe−/− Mice: Isoform-Specific Effects on Neurodegeneration , 1999, The Journal of Neuroscience.
[273] Masahiko Watanabe,et al. Apo E structure determines VLDL clearance and atherosclerosis risk in mice. , 1999, The Journal of clinical investigation.
[274] R. Mahley,et al. Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. , 1999, Current opinion in lipidology.
[275] J. Gilbert,et al. Differential neurotrophic effects of apolipoprotein E in aged transgenic mice , 1999, Neuroscience Letters.
[276] E. Stadtman,et al. Methionine residues may protect proteins from critical oxidative damage , 1999, Mechanisms of Ageing and Development.
[277] J. Gilbert,et al. Specific regional transcription of apolipoprotein E in human brain neurons. , 1999, The American journal of pathology.
[278] A. Delacourte,et al. Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele , 1998, Neuroscience Letters.
[279] N. Maeda,et al. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. , 1998, The Journal of clinical investigation.
[280] H Okada,et al. Altered glucose metabolism in the hippocampal head in memory impairment , 1998, Neurology.
[281] M. Graeber,et al. Microglial Activation in Alzheimer Disease: Association with APOE Genotype , 1998, Brain pathology.
[282] J. Haines,et al. Effects of Age and Ethnicity on the Link Between APOE ∊4 and Alzheimer Disease—Reply , 1998 .
[283] R. Demattos,et al. A Minimally Lipidated Form of Cell-derived Apolipoprotein E Exhibits Isoform-specific Stimulation of Neurite Outgrowth in the Absence of Exogenous Lipids or Lipoproteins* , 1998, The Journal of Biological Chemistry.
[284] E. Gruenstein,et al. Rapid elevation of neuronal cytoplasmic calcium by apolipoprotein E peptide , 1997, Journal of cellular physiology.
[285] N. Maeda,et al. Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis* , 1997, The Journal of Biological Chemistry.
[286] Jonathan D. Smith,et al. Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.
[287] M. Nakai,et al. Expression of apolipoprotein E mRNA in rat microglia , 1996, Neuroscience Letters.
[288] T. Montine,et al. Crosslinking of Apolipoprotein E by Products of Lipid Peroxidation , 1996, Journal of neuropathology and experimental neurology.
[289] E Brisch,et al. The Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization (*) , 1995, The Journal of Biological Chemistry.
[290] J C Mazziotta,et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. , 1995, JAMA.
[291] D. Agard,et al. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. , 1994 .
[292] T. Hayek,et al. Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. , 1994, Biochemical and biophysical research communications.
[293] A. M. Saunders,et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.
[294] R. Mahley,et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.
[295] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[296] A. D. Roses,et al. Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .
[297] E. Shooter,et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. , 1989, The Journal of clinical investigation.
[298] R. Mahley,et al. Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state , 1988, The Journal of cell biology.
[299] R. Mahley,et al. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.
[300] R. E. Pitas,et al. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. , 1987, The Journal of biological chemistry.
[301] J. Taylor,et al. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. , 1985, The Journal of clinical investigation.
[302] R J Havel,et al. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. , 1982, Journal of lipid research.
[303] J. Breslow,et al. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. , 1981, Biochemistry.
[304] A. Bruni,et al. The Genetic Variability of UCP4 Affects the Individual Susceptibility to Late-Onset Alzheimer's Disease and Modifies the Disease's Risk in APOE-ɛ4 Carriers. , 2016, Journal of Alzheimer's disease : JAD.
[305] Liqin Zhao,et al. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention. , 2015, Journal of Alzheimer's disease : JAD.
[306] Emily H. Trittschuh,et al. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. , 2015, Journal of Alzheimer's disease : JAD.
[307] R. T. Alexander,et al. Traditional and emerging roles for the SLC9 Na+/H+ exchangers , 2013, Pflügers Archiv - European Journal of Physiology.
[308] Suzanne Craft,et al. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[309] R. Rimondini,et al. Combination of apolipoprotein E4 and high carbohydrate diet reduces hippocampal BDNF and arc levels and impairs memory in young mice. , 2012, Journal of Alzheimer's disease : JAD.
[310] Men-Tzung Lo,et al. Impaired Cerebral , 2012 .
[311] S. Coons,et al. Deficits in spatial learning and memory is associated with hippocampal volume loss in aged apolipoprotein E4 mice. , 2011, Journal of Alzheimer's disease : JAD.
[312] Susan M. Resnick,et al. APOE ε 4 GENOTYPE AND LONGITUDINAL CHANGES IN CEREBRAL BLOOD FLOW IN NORMAL AGING , 2010 .
[313] S. Caplan,et al. The early endosome: a busy sorting station for proteins at the crossroads. , 2010, Histology and histopathology.
[314] Y. Y. Tam,et al. The Endocytic Pathway , 2009 .
[315] Gerald Rimbach,et al. Impact of apoE genotype on oxidative stress, inflammation and disease risk. , 2008, Molecular nutrition & food research.
[316] K. Weisgraber,et al. Apolipoprotein E4 Forms a Molten Globule A POTENTIAL BASIS FOR ITS ASSOCIATION WITH DISEASE* , 2002 .
[317] R. Mahley,et al. Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.
[318] G. Siest,et al. Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. , 2000, Free radical biology & medicine.
[319] K. Weisgraber. Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.
[320] D. Russell,et al. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. , 1985, Annual review of cell biology.